Zebrafish Disease Models Market, Global Outlook and Forecast 2023-2030
The zebrafish is an important and widely used vertebrate model organism in scientific research, for example in drug development, in particular pre-clinical development. It is also notable for its regenerative abilities, and has been modified by researchers to produce many transgenic strains.
This report aims to provide a comprehensive presentation of the global market for Zebrafish Disease Models, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Zebrafish Disease Models. This report contains market size and forecasts of Zebrafish Disease Models in global, including the following market information:
Global Zebrafish Disease Models Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global Zebrafish Disease Models market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Epilepsy Model Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Zebrafish Disease Models include Shanghai Model Organisms Center, Inc., ZeClinics, InVivo Biosystems, Biobide, Pentagrit, Evotec, Aurigene Pharmaceutical Services, Ikan Biotech and Bioreperia, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Zebrafish Disease Models companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Zebrafish Disease Models Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Zebrafish Disease Models Market Segment Percentages, by Type, 2022 (%)
Epilepsy Model
Parkinson Disease Model
Retinal Degeneration Model
Metabolic Disorders and Obesity Model
Global Zebrafish Disease Models Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Zebrafish Disease Models Market Segment Percentages, by Application, 2022 (%)
Pharmaceutical
Biotechnology
Global Zebrafish Disease Models Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Zebrafish Disease Models Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Zebrafish Disease Models revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Zebrafish Disease Models revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Shanghai Model Organisms Center, Inc.
ZeClinics
InVivo Biosystems
Biobide
Pentagrit
Evotec
Aurigene Pharmaceutical Services
Ikan Biotech
Bioreperia
Hangzhou Hunter Biotechnology Co., Ltd.
YSY BIOTECH
Eze-Rinka
INVENesis
FEIFAN TEST
Charles River Laboratories
Outline of Major Chapters:
Chapter 1: Introduces the definition of Zebrafish Disease Models, market overview.
Chapter 2: Global Zebrafish Disease Models market size in revenue.
Chapter 3: Detailed analysis of Zebrafish Disease Models company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Zebrafish Disease Models in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
